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Background and Objective:  Acute pharyngitis is a common diagnosis in ambulatory pediatrics.  
The Infectious Diseases Society of America (IDSA) clinical practice guideline for group A 
streptococcal (GAS) pharyngitis recommends strict criteria for GAS testing to avoid misdiagnosis 
and unnecessary treatment of colonized children.  We sought to improve adherence to the IDSA 
guideline for testing and treatment of GAS pharyngitis in a large community pediatrics practice.  
Methods: The Model for Improvement was used and iterative Plan-Do-Study-Act (PDSA) cycles 
were completed in a Maintenance of Certification quality improvement project.  Interventions 
included: provider education, modification of an existing office procedure, communication 
strategies, and patient/family education.  Outcomes were assessed utilizing statistical process 
control charts.  Results: Unnecessary GAS testing decreased by 17% (from 64% to 47%) during 
the project.  Presence of viral symptoms was the primary reason for unnecessary testing.  
Appropriate antibiotic utilization did not significantly change during the project.  At the end of the 
intervention period the majority of providers perceived an improvement had occurred in their 
ability to communicate with families about the need for GAS pharyngitis testing and about 
antibiotic use.  Conclusions: The majority of GAS pharyngitis testing in this practice was 
inconsistent with guideline recommendations for testing prior to intervention.  A Maintenance of 
Certification quality improvement initiative led to improvement in guideline-based testing for 
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Pharyngitis is common in children, resulting in more than 11 million pediatric ambulatory 
care visits annually [1, 2].  While group A streptococcus (GAS) causes 15-37% of pharyngitis 
cases, the vast majority of acute pharyngitis cases are caused by viruses [1, 3, 4].  Correct diagnosis 
of the etiology of pharyngitis is necessary to provide appropriate treatment to limit sequelae in 
cases of GAS pharyngitis, but also to curb antibiotic overuse in non-streptococcal pharyngitis.  
Signs and symptoms alone are not reliable to diagnose GAS pharyngitis [5].  The Infectious 
Diseases Society of America (IDSA) clinical practice guideline recommends testing by rapid 
antigen detection test (RADT) with back-up culture for negative tests to diagnose GAS pharyngitis 
[6].  RADTs are highly specific for the presence of GAS [7].  However, RADT and throat culture 
do not distinguish between GAS infection and carrier state and up to 25% of children are 
asymptomatic carriers of GAS in the pharynx [4, 8].  Additionally, false positive tests can result 
from incorrect technique [9].  Clinical judgement must be used to determine which children should 
be tested for GAS pharyngitis to avoid misdiagnosis and unnecessary antibiotic exposure.   
Nationally, antibiotics are prescribed during 53-60% of pediatric visits for pharyngitis, 
nearly double the expected prevalence of GAS pharyngitis [1, 3, 10].  Since GAS pharyngitis is 
the only pharyngitis in children for which antibiotics are routinely indicated, the excess prescribing 
suggests that clinicians often inappropriately prescribe antibiotics in patients with non-
streptococcal pharyngitis.  Interventions are needed to eliminate excessive prescribing for pediatric 
pharyngitis.   
Antibiotic overuse for pharyngitis may result from non-indicated GAS pharyngitis testing 
[9].  Chart review of patients who had GAS pharyngitis testing performed in the Children’s Mercy 
Kansas City Emergency Department from February to April 2012 revealed 64% of testing was not 
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clinically indicated.  This unnecessary testing resulted in 158 unnecessary antibiotic prescriptions 
[11].   
Second-line antibiotics and unnecessarily broad-spectrum antibiotics are frequently 
prescribed for pharyngitis.  The IDSA guideline recommends penicillin or amoxicillin as the drug 
of choice for treatment of GAS pharyngitis in non-allergic patients.  A first generation 
cephalosporin, clindamycin, clarithromycin, or azithromycin are the recommended alternatives for 
penicillin-allergic patients with GAS pharyngitis.  Dooling et al. found that narrow-spectrum 
penicillins accounted for only 61% of antibiotic prescriptions for pediatric pharyngitis visits over 
a 14 year study period, followed by macrolides and first generation cephalosporins (21%) and 
second/third generation cephalosporins and amoxicillin/clavulanate (18%) [1].  Prescribing of 
narrow spectrum penicillins decreased during the study period.  Injudicious use of macrolides for 
GAS pharyngitis treatment is of particular concern given reports of substantial rates of macrolide 
resistance in GAS isolates [12].     
We partnered with a large community pediatric practice in a collaborative, 
interprofessional, quality improvement (QI) initiative to evaluate and improve testing for and 
treatment of GAS pharyngitis.  The goals of the project were to decrease unnecessary testing for 
GAS pharyngitis by 25% and improve antibiotic utilization for GAS pharyngitis by 25%.            
Methods 
Context   
The project was conducted at an ambulatory pediatric practice in Kansas City, MO.  The 
practice includes 12 board-certified pediatricians, 4 certified nurse practitioners, and 19 nurses.  
The practice cares for more than 40,000 children each year at two practice locations and received 
Patient-Centered Medical Home (PCMH) Level 3 designation from the National Committee for 
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Quality Assurance (NCQA).  The practice is involved in training pediatric residents and medical 
students.  Children’s Mercy Kansas City, a 354 bed free-standing children’s hospital, was the 
sponsoring institution for this QI project.  Children’s Mercy Kansas City is an American Board of 
Pediatrics approved Maintenance of Certification (MOC) Portfolio Sponsor.  This project was 
approved for MOC Part 4 credit. 
QI Team   
The team was led by a pediatric infectious diseases fellow (LEN) and a pediatric infectious 
diseases attending (ALM) at Children’s Mercy Kansas City.  The team leaders have formal training 
in QI methodology and provided content expertise.  Children’s Mercy QI leaders provided 
feedback throughout the project.   
Measures   
Two outcomes were measured for this project.  The first outcome measure was unnecessary 
GAS pharyngitis testing.  Unnecessary GAS pharyngitis testing was defined as a patient meeting 
at least 1 of the following criteria:  1) age < 3 years without documentation of a household contact 
with GAS pharyngitis, 2) presence of 2 or more viral symptoms, 3) absence of sore throat, or 4) 
absence of expected GAS pharyngitis exam findings.  Viral symptoms included: conjunctivitis, 
coryza, cough, diarrhea, hoarse voice, and viral exanthema.  These criteria, including the specific 
viral symptoms, were chosen based on recommendations from the IDSA clinical practice guideline 
for the diagnosis and management of GAS pharyngitis.  The decision to use 2 or more viral 
symptoms was made because providers involved in the project expressed a concern that 
documentation may not clearly reflect the timing or severity of symptoms (e.g. lingering cough 
after resolved viral respiratory tract infection) and they suspected viral symptoms would be over-
represented in retrospective chart review.   
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The second outcome measure was appropriate antibiotic utilization.  Appropriate antibiotic 
utilization was defined as: use of an antibiotic that was clinically indicated (necessary GAS 
pharyngitis testing performed and the test was positive) with selection of a first-line antibiotic, 
based on the patient’s documented penicillin allergy status, for the suitable duration (single dose 
for intramuscular penicillin, 5 days for azithromycin, 10 days for any other antibiotic used). 
Data Collection 
The project period was October 1, 2014-October 31, 2016.   A standardized abstraction 
form was used to collect information regarding demographics, symptoms and exposure history, 
exam findings, penicillin allergy status, antibiotic selection and antibiotic duration from a clinic 
encounter note.  A convenience sample of 20 patients per month was selected from patients with 
a current procedural terminology (CPT®) code, 87880, for streptococcal RADT.  The sample size 
was chosen based on minimum subgroup sizes needed to have upper and lower control limits on 
the control chart and ensure improvement is detectable using estimated baseline levels for our 
outcome measures [13].  Patient charts were excluded if RADT results were not documented.  A 
current state analysis was conducted at the start of the project using retrospective chart review of 
a convenience sample of 20 charts per month for a 12 month period (October 2013-September 
2014) to determine baseline levels for each outcome measure.  Due to lack of provider participation 
at the start of the project, the pre-intervention period was extended to June 2015 (Intervention 1).     
Planning the Interventions 
A fishbone diagram (Figure 1) was constructed to determine factors leading to unnecessary 
testing for GAS pharyngitis.  Meetings were held with stakeholders (providers and staff) at the 
practice site to identify key drivers and establish project aims (Figure 2).  A Pareto chart was used 
to determine which reasons for unnecessary testing should be targeted for improvement.  National 
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benchmark data were not available for these outcome measures.  The aims of this project were:  1) 
Decrease unnecessary testing for GAS pharyngitis in this ambulatory pediatric practice from 64% 
to 39% by October 31, 2016 and 2) Improve guideline-based antibiotic utilization for GAS 
pharyngitis in this ambulatory pediatric practice from 45% to 70% by October 31, 2016.    
Figure 1. Fishbone diagram identifying factors leading to unnecessary GAS pharyngitis testing. 
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Figure 2. Key driver diagram for improving testing for and management of GAS pharyngitis. 
Interventions  
Education. A webinar was presented to educate providers and staff regarding incidence of 
GAS pharyngitis, incidence of GAS colonization, complications of streptococcal pharyngitis, 
antibiotic complications, and a review of the IDSA guideline for diagnosis and management of 
GAS pharyngitis.  This webinar was offered at the start of the project period and repeated 2 months 
into the project.  Only two of sixteen providers participated in these webinars.  Due to the lack of 
provider participation in the webinars the same information was presented along with data from 
the current state analysis at an onsite, face-to-face meeting with providers (Intervention 1).  This 
meeting included an orientation to QI methodology.  Subsequently, an email update with a control 
chart depicting trends in the practice’s unnecessary GAS testing was sent to providers along with 
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a published commentary on the changing value of testing for and treating GAS pharyngitis 
(Intervention 2) [14].                      
Modification of an existing office procedure. This practice allowed a standing order for 
nursing staff to perform RADT on any patient presenting with sore throat prior to provider 
evaluation of the patient and regardless of associated signs or symptoms.  During the initial face-
to-face meeting with providers the practice agreed to eliminate this standing order and require 
provider evaluation of patients prior to GAS pharyngitis testing.  Intervention 1 included both the 
first face-to-face meeting as well as the date of the change in office procedure.   
Communication strategies. Discussions were held with providers regarding how to 
communicate with families about recommendations for testing and management of pharyngitis 
(Intervention 3).  Providers reported concerns about parental expectations for testing even when it 
was not indicated and parental request for second-line antibiotics based on a perception that 
amoxicillin was ineffective.  Strategies were provided to respond to these parental concerns.  These 
strategies were also discussed with staff at the practice during an onsite, face-to-face meeting with 
providers and staff where updates on outcome measures were presented (Intervention 4).  A one-
page handout outlining key points from these discussions was developed and distributed to families 
at the providers’ discretion (Intervention 5).      
Study of Interventions   
The Model for Improvement was used as a framework to guide this project [15].  Iterative 
Plan-Do-Study-Act cycles were completed.  Outcome measures were assessed on statistical 
process control charts using Excel QI Macros.  The effectiveness of the interventions was 
determined by presence of a shift (≥ 8 points above or below the centerline) indicating special 
cause variation, or a nonrandom pattern in the data as a result of a sustained change [16].  Ongoing 
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audit of outcome measures was performed throughout the intervention period with feedback 
provided to the practice at each face-to-face meeting.  A sub-analysis was performed to look for a 
trend in necessary antibiotic prescribing for pharyngitis over time.  This sub-analysis was 
conducted with interrupted time series by using a segmented logistic regression model to determine 
whether a difference in the slope of the line occurred after Intervention 1.  Necessary antibiotic 
prescribing was defined as a prescription provided to a patient whose GAS pharyngitis testing was 
clinically indicated and had a positive RADT result.  Antibiotics prescribed for diagnoses other 
than pharyngitis were excluded.  Providers were surveyed at the end of the project to assess their 
perception of the impact of the project on their individual practice. 
Post-hoc exploratory analysis was performed to examine individual provider-level 
unnecessary testing.  This analysis included retrospective chart review of additional charts not 
included in the primary analyses to ensure inclusion of at least 1 chart per provider per quarter 
beginning with data for July 2016.  Provider level data were not shared with the providers until the 
end of the intervention period.      
Ethical Considerations   
The project was considered a local quality improvement project and not human subjects 
research by the Children’s Mercy Kansas City Office of Research Integrity.  A data use agreement 
was executed between Children’s Mercy Kansas City and the practice involved in this project. 
Results 
A total of 709 patient charts were reviewed (392 from the pre-intervention period and 317 
from the intervention period).  The average level for unnecessary GAS pharyngitis testing per 
month was 63.6% prior to Intervention 1.  This average decreased to 46.5% during the 
intervention period (Figure 3).  Following Intervention 2 there was evidence of special cause 
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variation with eleven points below the baseline average.  The presence of viral symptoms was 
the most frequently observed criteria for unnecessary testing followed by absence of documented 
sore throat.  Testing of patients with viral symptoms and patients less than 3 years old decreased 
during the project period (Figure 4). 
 
Figure 3.  P-chart for proportion of patients with unnecessary GAS pharyngitis testing over time. 
LCL, lower control limit; UCL, upper control limit. Intrv #1. Face-to-face meeting, modification 
of office procedure (06/26/15) Intrv #2. Email update (10/29/15) Intrv #3. Face-to-face meeting, 
communication strategies with providers (04/22/16) Intrv #4. Face-to-face meeting, 




Figure 4. Bar and line graphs of reasons for unnecessary GAS pharyngitis testing over time. LT, 
less than. 
 
Post-hoc analysis revealed large differences in unnecessary testing between providers 
within the practice (Figure 5).  Differences were observed in the slope of the linear trend 
between providers.  An increasing linear trend in unnecessary testing over time was observed for 




Figure 5. Spaghetti plot of linear trend for quarterly proportions of unnecessary GAS pharyngitis 
testing for individual providers over time.  Solid lines represent linear trend for indiviual 
providers.  Dashed line represents linear trend for all providers. 
 
The centerline for appropriate antibiotic utilization per month was 49% throughout the 
entire project with a random pattern of data indicating common cause variation (Figure 6).  
Unnecessary GAS pharyngitis testing was the most frequently observed criteria for inappropriate 
antibiotic utilization throughout the pre-intervention and intervention periods (Table 1).  Over 
the course of the project, including the baseline period, 119 unnecessary antibiotic courses were 
prescribed for pharyngitis.  There was no change in the slope of the linear trend of necessary 
prescribing after Intervention 1.  Throughout the baseline period and the entirety of the project 




Figure 6. P chart for proportion of antibiotic prescriptions that met criteria for appropriate 
utilization (clinically indicated, appropriate selection, appropriate duration) over time.  LCL, 
lower control limit; UCL, upper control limit  
 
Table 1.   Reasons for Inappropriate Antibiotic Utilization 
Reason Number of Patients 
Unnecessary GAS Pharyngitis Testing 116 
Negative GAS RADT Result 6 
Inappropriate Antibiotic Selection 36 




The provider survey response rate was 100% (16/16).  All providers responded 
affirmatively when asked if this project was meaningful and if they would participate in a similar 
project again.  Additionally, most providers (88%) believed their ability to communicate with 
families about the need for testing and about antibiotic use improved during the project.  The 
majority of providers (94%) believed that the project did not negatively impact clinic efficiency.  
Spontaneous responses to inquiry about what had the greatest impact on reducing unnecessary 
GAS pharyngitis testing in their practice included: “limiting nurses from testing kids with URI 
symptoms,” “specific criteria for testing,” and “education on best practice.” 
Discussion 
Injudicious use of GAS pharyngitis testing may lead to avoidable healthcare costs, 
unnecessary antibiotic exposure, and unintended harms [14].  Our results suggest that an 
interprofessional collaboration using QI methods can successfully improve adherence to 
guideline-based GAS pharyngitis testing in ambulatory pediatric practice.  Additionally, these QI 
methods were associated with provider perception of improved ability to communicate with 
families about the need for GAS pharyngitis testing and about antibiotic use.  Despite a reduction 
in unnecessary testing, a significant improvement in antibiotic utilization was not observed 
during the project underscoring the need for further efforts.     
The majority of GAS pharyngitis testing in this practice was inconsistent with guideline 
recommendations for testing prior to intervention.  The use of ≥ 2 viral symptoms as a criteria to 
determine unnecessary testing may even underestimate unnecessary testing.  The decision to use 
this criteria is supported by a recent publication by Shapiro et al. in which they found an inverse 
relationship between number of viral features and the prevalence of GAS pharyngitis 
demonstrating that patients with ≥ 2 viral features were > 40% less likely to have GAS 
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pharyngitis compared to patients with no viral features [17].  Additionally, when we examined a 
subset of baseline data for our project (196 charts of patients > 3 years of age) the odds of a 
positive RADT for patients with 1 viral symptom was non-significant (OR: .665; CI: .332, 1.33; 
p-value: 0.2494) when compared to patients with no viral symptoms; statistical significance was 
observed for patients with ≥ 2 viral symptoms (odds ratio: 0.372; CI: 0.171, 0.809; p: 0.0127) 
when compared to patients with no viral symptoms. The use of a conservative estimate of 
unnecessary testing would not be expected to affect the proportion of reduction that was 
observed which was the focus of this project.   
A number of local factors were key to reducing unnecessary testing.  The practice 
involved in this project prioritizes delivery of high-quality healthcare as evidenced by their 
PCMH Level 3 designation from NCQA.  The practice was receptive to process change 
including modification of an existing office procedure which likely contributed to the observed 
improvement in guideline-based testing.  Additionally, physicians received MOC Part 4 credit 
for their work on this project which incentivized their engagement.  Faculty engagement in an 
MOC project, along with other interventions, was previously used to successfully improve 
adolescent pregnancy screening rates [18].    
Despite these local contextual factors, we still observed variability in unnecessary GAS 
pharyngitis testing between providers within this practice.  We suspect that these differences 
were the reason we did not observe the magnitude of reduction in unnecessary GAS pharyngitis 
testing for which we aimed.  Cognitive bias likely played a role in the observed baseline rate of 
unnecessary GAS pharyngitis testing and may have played a role in the ongoing variation 
between providers.  Providers reported a fear of missed diagnosis and the complications that 
could result as a driver of their decision to perform GAS pharyngitis testing.  We recognized that 
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base rate neglect played a role in their assessment of the need for testing as they over-estimated 
the risk for complications associated with GAS pharyngitis and under-estimated risks associated 
with antibiotic use [19].   
Our project design relied primarily on educational interventions.  Prior studies 
demonstrate that passive educational interventions result in limited sustainable improvement 
[20].  Face-to-face educational outreach, involvement of local opinion leaders, and a 
combination of interventions deployed simultaneously have been used to successfully create 
quality improvement [21].  We combined educational interventions with some of these methods 
to increase stakeholder buy-in and audit with feedback on performance in outcome measures to 
achieve greater improvement.  Despite these efforts not all providers achieved reductions in 
unnecessary GAS pharyngitis testing.  Our results underscore the challenges associated with 
quality improvement initiatives aimed at modifying provider behavior and highlight the 
importance of provider buy-in to achieve improvement.  The post-hoc provider-level exploratory 
analysis allows identification of specific providers who can be targeted for individualized future 
interventions.  Additionally, future projects evaluating the use of higher reliability interventions, 
such as decision support tools embedded in electronic health records, are needed.   
We aimed for improvement in antibiotic utilization following our interventions.  Our 
definition encompassed clinical indication, antibiotic selection, and antibiotic duration.  
Adherence to guideline-based first-line antibiotic selection was higher in this practice than 
published national data leaving little room for improvement in antibiotic selection [1].  
Adherence to guideline-based antibiotic duration was also high.  Prescribing of antibiotics to 
patients with unnecessary GAS pharyngitis testing remained the primary reason for inappropriate 
antibiotic utilization before and after intervention.  These data suggest that a larger reduction 
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than we observed in unnecessary GAS pharyngitis testing is needed to significantly improve 
antibiotic utilization for GAS pharyngitis.  Further efforts are needed to tackle the important 
national problem of antibiotic overuse for pediatric pharyngitis.                 
Our project has limitations.  Multiple PDSA cycles were introduced in a 6 month period 
making it difficult to know which intervention had the greatest impact.  The QI infrastructure 
available for our project may not be available in smaller practices which may limit generalizability 
of our results to smaller practices.  The sample was selected from patients based on GAS 
pharyngitis testing and not based on antibiotic prescribing or clinical presentation.  This sampling 
method resulted in small sample sizes of antibiotic prescriptions each month.      
Conclusions 
Our collaborative, interprofessional QI initiative was successful in reducing unnecessary 
GAS pharyngitis testing in a large community pediatric practice.  Interventions utilized to 
achieve improvement included provider and patient/family education, modification of office 
procedure, and communication strategies with periodic feedback provided on performance in 
outcome measures.  Important contextual factors included QI infrastructure, provider buy-in, and 
MOC status of the project.  Additional work is needed to identify higher reliability interventions 
which reduce variability in testing practices between providers and result in improved antibiotic 
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